GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Energenesis Biomedical Co 6657.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

29.65

+0.17%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 7.7m

FY2016FY2025

Net income

−TWD 258.4m

FY2016FY2025

Free cash flow

−TWD 224.7m

FY2016FY2025

Shareholders' equity

TWD 896.3m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 7.7mTWD 7.7mTWD 7.2mTWD 7.4mTWD 7.5mTWD 7.1mTWD 6.3mTWD 4.7mTWD 5.2mTWD 6.0m
Gross profitTWD 5.8mTWD 5.7mTWD 5.2mTWD 5.2mTWD 5.4mTWD 4.8mTWD 3.9mTWD 2.8mTWD 3.0mTWD 3.6m
Research and developmentTWD 181.8mTWD 179.8mTWD 185.1mTWD 213.7mTWD 61.8mTWD 72.4mTWD 98.2mTWD 62.5mTWD 47.6mTWD 26.2m
Operating income−TWD 275.3m−TWD 255.2m−TWD 261.8m−TWD 265.5m−TWD 120.0m−TWD 129.1m−TWD 149.2m−TWD 108.7m−TWD 72.9m−TWD 35.8m
Net income−TWD 258.4m−TWD 231.1m−TWD 260.4m−TWD 265.7m−TWD 120.2m−TWD 129.5m−TWD 149.8m−TWD 104.7m−TWD 70.6m−TWD 35.2m
Diluted earnings per share-2.91-3.01-3.42-4.19-2.00-2.19-2.84-2.30-2.21-1.50

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 949.0mTWD 780.6mTWD 828.6mTWD 630.9mTWD 885.8mTWD 705.4mTWD 813.6mTWD 499.5mTWD 304.3mTWD 271.4m
Cash and short-term investmentsTWD 838.1mTWD 665.0mTWD 699.2mTWD 484.7mTWD 725.8mTWD 543.9mTWD 642.6mTWD 333.3mTWD 127.6mTWD 87.4m
Total liabilitiesTWD 52.7mTWD 41.3mTWD 24.6mTWD 28.3mTWD 33.4mTWD 32.5mTWD 27.1mTWD 47.0mTWD 49.1mTWD 43.0m
DebtTWD 5.6mTWD 10.0mTWD 8.3mTWD 9.5mTWD 11.9mTWD 14.9mTWD 12.2mTWD 34.7mTWD 34.7mTWD 35.0m
Shareholders' equityTWD 896.3mTWD 739.3mTWD 804.0mTWD 602.6mTWD 852.4mTWD 672.9mTWD 786.5mTWD 452.5mTWD 255.2mTWD 228.4m
Shares outstanding89m77m76m63m60m59m53m46m32m23m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 222.4m−TWD 180.7m−TWD 225.0m−TWD 232.8m−TWD 97.3m−TWD 98.9m−TWD 121.2m−TWD 85.0m−TWD 43.7m−TWD 20.9m
Capital spending−TWD 2.3m−TWD 754,000−TWD 844,000−TWD 6.6m−TWD 8.9m−TWD 4.6m−TWD 1.9m−TWD 2.7m−TWD 7.2m−TWD 4.0m
Free cash flow−TWD 224.7m−TWD 181.5m−TWD 225.9m−TWD 239.4m−TWD 106.2m−TWD 103.5m−TWD 123.1m−TWD 87.8m−TWD 50.9m−TWD 24.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 1.9mTWD 1.4mTWD 2.8mTWD 1.6mTWD 2.1mTWD 1.2mTWD 2.6mTWD 2.1m
Gross profit−TWD 1.2m−TWD 2.5mTWD 2.0mTWD 1.2mTWD 1.6mTWD 980,000TWD 1.9mTWD 1.4m
Operating income−TWD 141.0m−TWD 50.8m−TWD 69.4m−TWD 52.6m−TWD 52.4m−TWD 100.8m−TWD 54.7m−TWD 91.5m
Net income−TWD 138.5m−TWD 46.3m−TWD 64.8m−TWD 49.0m−TWD 47.6m−TWD 97.0m−TWD 49.9m−TWD 89.7m
Diluted earnings per share-1.58-0.53-0.73-0.55-0.54-1.09-0.65-1.17
Cash from operations−TWD 95.0m−TWD 49.0m−TWD 49.0m−TWD 35.0m−TWD 52.0m−TWD 115.0m−TWD 1.0m−TWD 76.0m
Capital spending———−TWD 1.0m————
Free cash flow———−TWD 36.0m————
Total assetsTWD 784.1mTWD 883.8mTWD 949.0mTWD 1.03bnTWD 1.07bnTWD 1.12bnTWD 780.6mTWD 673.2m
Cash and short-term investmentsTWD 677.4mTWD 775.6mTWD 838.1mTWD 918.5mTWD 954.6mTWD 1.01bnTWD 665.0mTWD 556.2m
DebtTWD 4.9mTWD 5.2mTWD 5.6mTWD 5.8mTWD 4.9mTWD 5.2mTWD 4.6mTWD 4.4m
Shareholders' equityTWD 712.9mTWD 849.1mTWD 896.3mTWD 994.0mTWD 1.04bnTWD 1.08bnTWD 739.3mTWD 643.5m

Financial ratios

Data as of 19 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin76.0%73.4%73.0%70.3%71.6%68.1%
Operating margin-3587.1%-2979.3%-3658.0%-3611.1%-1601.7%-1823.6%
Net margin-3367.2%-2982.1%-3637.6%-3614.0%-1605.5%-1828.5%
Return on equity-28.8%-31.3%-32.4%-44.1%-14.1%-19.2%
Return on assets-27.2%-29.6%-31.4%-42.1%-13.6%-18.4%
Free cash flow yield-7.1%-6.8%-8.5%-10.3%——
Revenue growth-1.0%8.3%-2.6%-1.8%5.8%13.3%
Earnings growth11.8%-11.3%-2.0%121.0%-7.1%-13.5%
Current ratio19.91x19.19x33.71x20.67x27.16x24.33x
Debt to equity0.01x0.01x0.01x0.01x0.01x0.01x
Equity ratio94.4%94.7%97.0%95.5%96.2%95.4%
Interest coverage-594.55x-1089.00x-1223.54x-1270.12x-422.37x-368.94x
R&D as a share of sales2369.4%2320.9%2586.3%2906.8%824.7%1022.9%
Buybacks as a share of market value-15.9%-0.7%-20.1%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1.4%1.6%12.5%
Operating income1.2%16.3%33.5%
Net income-0.9%14.8%33.1%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin74.7%73.2%72.1%67.6%
Operating margin-3439.3%-3533.8%-2936.5%-2449.0%
Net margin-3173.7%-3392.8%-2843.1%-2378.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-14.8-16.9-17.6-10.1-22.5-22.4-28.4-20.1
Price to sales498.0——366.2361.3409.6—452.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.